NCT05674149

Brief Summary

This is an observational, single-center, open-label photography evaluation. Any patient that arrives for consultation or treatment at the clinic, presenting the required lesions detailed in the protocol can be included.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

June 21, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

December 19, 2023

Status Verified

December 1, 2023

Enrollment Period

8 months

First QC Date

November 25, 2022

Last Update Submit

December 18, 2023

Conditions

Vascular LesionPigmented Lesions

Outcome Measures

Primary Outcomes (1)

  • Images collection

    Images of different skin condition will be collected using multispectral camera

    through study completion, up to 4 months

Secondary Outcomes (1)

  • Images data collection

    through study completion, up to 4 months

Study Arms (1)

Multi-Spectral Camera

OTHER

Multi-Spectral Camera will be used in order to capture images of different skin conditions

Device: camera

Interventions

cameraDEVICE

photographs using multi-spectral camera

Multi-Spectral Camera

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient, male or female of at least 18 years old, who is willing to sign an informed consent form and present at least one of the following conditions:
  • Photoaging (type I - III per Glogau classification)- mixed conditions
  • Epidermal pigmentation / Lentigines (age spots, sun spots)
  • Facial rosacea (Erythematotelangiectatic rosacea and papulopustular rosacea)
  • Facial telangiectasia
  • Poikiloderma
  • Seborrheic keratosis
  • Melasma (Chloasma)

You may not qualify if:

  • Any of the following will exclude the subject from the study:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ha'Emek Medical Center

Afula, 20692, Israel

RECRUITING

Central Study Contacts

Rula Masoud, PhD

CONTACT

0503018155rula.masoud@lumenis.com

Michael Ziv, MD

CONTACT

ziv_mi@clalit.org.il

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2022

First Posted

January 6, 2023

Study Start

June 21, 2023

Primary Completion

March 1, 2024

Study Completion

March 1, 2024

Last Updated

December 19, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations

IL(1)